Be a Smart Investor
Friday, January 31, 2020
FDA Approves Aimmune's (AIMT) Palforzia, Stock Up 17% In After-Hours
The FDA has approved Aimmune Therapeutics Inc.'s (AIMT) Palforzia for the treatment of peanut allergy in patients aged 4 through 17 years.
from RTT - Biotech https://ift.tt/391pXXJ
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment